<SEC-DOCUMENT>0000950170-24-038136-index.html : 20240328
<SEC-HEADER>0000950170-24-038136.hdr.sgml : 20240328
<ACCEPTANCE-DATETIME>20240328164739
ACCESSION NUMBER:		0000950170-24-038136
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240328
DATE AS OF CHANGE:		20240328
EFFECTIVENESS DATE:		20240328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278335
		FILM NUMBER:		24799915

	BUSINESS ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>achv_march_2024_form_s-8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: achv_march_2024_form_s-8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>achv-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: achv-ex5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>achv-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: achv-ex23_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>achv-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: achv-exfiling_fees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img223336490_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img223336490_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>